Physician profile
Michael Bilkis
NPI 1235166349
$2,417.10
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $994 · 2020: $706 · 2021: $718.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $419.21 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $330.69 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $265.68 | 2019-2021 | |
| Pfizer INC. | $248.12 | 2019-2021 | |
| Lilly USA, LLC | $163.83 | 2019-2021 | |
| Janssen Biotech, INC. | $155.85 | 2019-2021 | |
| Abbvie INC. | $150.50 | 2019-2021 | |
| Galderma Laboratories, L.P. | $123.32 | 2019-2020 | |
| Dermira, INC. | $80.34 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $69.35 | 2019-2021 | |
| Vyne Pharmaceuticals INC. | $62.59 | 2020-2021 | |
| Sebela Pharmaceuticals INC. | $58.54 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $46.03 | 2019-2020 | |
| Ucb, INC. | $45.64 | 2019-2021 | |
| Almirall LLC | $41.92 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prugen, INC. Pharmaceuticals | $38.89 | 2019 | |
| Amgen INC. | $29.00 | 2019-2021 | |
| Genzyme Corporation | $28.08 | 2019-2021 | |
| Journey Medical Corporation | $21.52 | 2019 | |
| Leo Pharma INC. | $15.00 | 2020 | |
| Aclaris Therapeutics, INC. | $11.90 | 2019 | |
| Epi Health, LLC | $11.10 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bilkis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.